Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) were up 6.7% during mid-day trading on Thursday . The company traded as high as $17.04 and last traded at $17.01. Approximately 1,786,954 shares were traded during mid-day trading, a decline of 44% from the average daily volume of 3,194,686 shares. The stock had previously closed at $15.94.
Analyst Upgrades and Downgrades
OSCR has been the subject of several research analyst reports. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective for the company. Piper Sandler reiterated an "overweight" rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Three investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $24.00.
Get Our Latest Stock Report on Oscar Health
Oscar Health Trading Up 7.9 %
The stock has a 50 day moving average of $18.87 and a 200 day moving average of $18.31. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. The firm had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company's revenue was up 44.6% on a year-over-year basis. During the same period in the prior year, the company earned ($0.07) EPS. As a group, sell-side analysts anticipate that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.
Insider Buying and Selling at Oscar Health
In related news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the sale, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Ranmali Bopitiya sold 36,175 shares of the firm's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $650,788.25. Following the transaction, the executive vice president now owns 251,885 shares in the company, valued at approximately $4,531,411.15. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 169,569 shares of company stock worth $3,007,069 over the last ninety days. Insiders own 25.11% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in OSCR. Avalon Trust Co purchased a new position in Oscar Health during the 1st quarter valued at about $69,000. Point72 Hong Kong Ltd bought a new stake in shares of Oscar Health in the 2nd quarter worth approximately $78,000. Quest Partners LLC purchased a new position in shares of Oscar Health during the second quarter valued at approximately $93,000. Optimum Investment Advisors bought a new position in shares of Oscar Health during the third quarter valued at approximately $142,000. Finally, Amalgamated Bank lifted its stake in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company's stock worth $106,000 after acquiring an additional 1,458 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.
About Oscar Health
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
